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Sinonasal teratocarcinosarcoma is a rare aggressive malignant tumor characterized by complex admixture of teratomatous and carcinosarcomatous component [1]. 
In literature, different names have been documented such as 
blastemal, malignant teratoma, and teratocarcinoma. First 
reported case was by Shanmugaratnam et al. under the term 
“teratoid carcinosarcoma” [2]. Later in 1984, Heffner and 
Hyams reported a series of similar cases modifying the term 
as “teratocarcinosarcoma” [3]. Till now, around 66 cases have 
been documented [4]. The lesion is often misdiagnosed due to 
rarity and the complex phenotypic composition and inadequate 
sampling. We present a rare case report from North-East India 
along with related review of literature of the same.
CASE REPORT
A 72-year-old male presented with complaints of epistaxis, 
recurrent sinusitis, nasal stuffiness, and nasal blockade for past 
5-6 months and was being treated in an outside private clinic. 
There was no significant past medical or family history (non-
tobacco user), and his physical examination did not reveal any 
abnormal systemic features. The clinical diagnosis was made 
as allergic polyp based on endoscopic findings of multiple tiny 
smooth gray white glistening polypoidal masses. His computed 
tomography scan also showed inflammatory sinonasal disease 
with polyposis at places including left sided nasal choanal polyp 
and his routine investigations were within normal limit. The 
patient had undergone polypectomy at outside clinic and biopsy 
was sent to our hospital.
The specimen was sent in 3 containers and grossly consists of 
multiple fragmented bits of tissue collectively amounting from 
2.5 × 2.5 × 2 cm3 to 1.5 cm across, gray white to gray brown 
in color. Histopathology sections showed fragments of the upper 
respiratory mucosa lined by ciliated columnar epithelium admixed 
with fragments of tumor composed of benign and malignant 
counterparts of both epithelial and mesenchymal components in 
a variety of histologic patterns. Also noted were the characteristic 
squamous epithelium with “fetal-type” clear cells (Fig. 1), areas 
of necrosis and increased mitotic figure. There were sheets of 
densely-packed small cells with scanty cytoplasm and uniform 
rounded nuclei resembling undifferentiated blastemal cells 
with proliferative neuroepithelium in the form of tubules. This 
primitive neural tissue was surrounded by myxoid area (Fig. 2) 
with elongated or rounded nuclei with intervening bundles of 
fibroblastic cells (Fig. 3).
Immunohistochemistry (IHC) demonstrated positive 
staining for cytokeratin, epithelial membrane antigen, vimentin, 
synaptophysin, S-100, chromogranin, GFAP, and CD99 
(Figs. 4-6). This poly immunophenotypic characteristic and 
diverse histological differentiation provided the basis for the 
diagnosis of sinonasal teratocarcinoma. Further, the patient was 
referred for radiation therapy, and he was responding well. The 
patient has been closely followed up without any complaints for 
last 6 months.
ABSTRACT
Sinonasal teratocarcinosarcoma is a rare and highly malignant tumor characterized by complex admixture of teratomatous and 
carcinosarcomatous component. Here, we report a case of 72-year-old male presented with complaints of epistaxis, recurrent sinusitis, 
nasal stuffiness, and nasal blockade for past 5-6 months and his computed tomography report revealed as an inflammatory sinonasal 
disease with polyposis. Histopathology examination showed fragments of upper respiratory mucosa admixed with fragments of 
tumor composed of benign and malignant counterparts of both epithelial and mesenchymal components in a variety of histologic 
patterns. Also noted were the characteristic squamous epithelium with “fetal-type” clear cells, areas of necrosis, mitotic figure and 
sheets of undifferentiated blastemal like cells. Immunohistochemistry demonstrated positive staining for cytokeratin, epithelial 
membrane antigen, vimentin, synaptophysin, S-100, chromogranin, and CD99. This polyimmunophenotypic characteristic and 
diverse histological differentiation provided the basis for the diagnosis. Knowing its highly aggressive behavior, the patient should 
be treated aggressively and followed up closely.
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DISCUSSION
Teratocarcinosarcoma, a rare highly malignant polymorphous 
neoplasm that displays combined features of an immature or malignant 
teratoma and a carcinosarcoma. It often tends to occur in the nose, 
pharynx and sinus areas, but tumor in other parts of the body has 
also been recorded. Clinical features are determined by the size and 
location of the tumor. The most common complaints at presentation 
include nasal obstruction, epistaxis, facial pain, headache, proptosis, 
and visual field deficits [2]. This neoplasm is more commonly seen 
in male with male to female ratio 4:1 and between 18 and 79 years 
of age [2]. Our patient was 72-year-old male presented with most 
common presentation such as epistaxis and nasal blockade.
Teratocarcinosarcoma is highly aggressive and locally 
recurrent tumor. Less is known about its metastatic potential 
Figure 1: H and E, ×20, squamous epithelium with “fetal-type” clear 
cells and myxoid area
Figure 2: H and E, ×20, neural tubules and blastemal cells
Figure 3: H and E, ×20, bundles of fibroblastic cells
Figure 4: Immunohistochemistry, ×20, CD99 positivity in blastemal 
cells
Figure 5: Immunohistochemistry, ×20, S100 positivity in neural 
tubular epithelium
Figure 6: Immunohistochemistry, ×40, cytokeratin positive fetal 
epithelium
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except very few reports mentioning about their metastatic potential 
to regional lymph nodes as well as in the lungs [5]. Hence, this 
very aggressive tumor requires multidisciplinary approach. 
Surgical resection with post-operative radiotherapy being the 
widely accepted therapeutic plan [5,6]. Role of chemotherapy 
is controversial; however, Sharma et al. have reported effective 
control of tumor recurrence under control (for a short period) with 
adjuvant chemotherapy [6]. Good responses were showed when 
adjuvant multidrug chemotherapy with cisplatin, etoposide, and 
ifosfamide was used [7].
Recently, Joshi et al. 2015 [8] have reported a recurrent case 
of sinonasal carcinosarcoma which was inoperable because of its 
cranial extension, and he was treated with palliative chemotherapy 
with ifosfamide and doxorubicin, and the patient showed 
significant symptomatic relief. Despite aggressive treatment, the 
prognosis is poor. The local recurrence after excision was found 
to be high with reported 3 and 5 years survival rates of about 30% 
and 20%, respectively [8]. Our patient was given radiotherapy, 
and he was responding well. For the last 6 months, he has 
been closely followed up without any complaints. Differential 
diagnosis includes poorly differentiated carcinoma, sarcoma, and 
olfactory neuroblastoma. IHC helps to rule out the differential 
diagnosis.
CONCLUSION
Sinonasal teratocarcinosarcoma is a rare and highly malignant 
tumor. “Fetal-type” clear cells squamous epithelium and 
immature neuroepithelium represent an important histologic clue 
to the histomorphological diagnosis and poly immunophenotypic 
characteristic in IHC provides the basis for its diagnosis. Knowing 
its highly aggressive behavior, the patient should be closely 
followed up, and chemotherapy can be integrated as an adjuvant 
or palliative setting.
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